
Pharma exporters expect Trump to act benevolently to them
Mumbai: Large Indian drug makers, some of which get as much as half their revenue from the US market, may have to work out options to pass on the impact of the tariff that Washington announced Wednesday. However, analysts and industry insiders said the …